推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 全球經(jīng)濟(jì)和世界各地高需求造成藥材價(jià)格猛漲，中藥不再像以往那樣便宜。馬來西亞華人醫(yī)藥總會(huì)會(huì)長陳凱希說，由于林吉特(馬來西亞貨幣)走弱，現(xiàn)在從中國進(jìn)口中藥材的成本變高。2015年4月實(shí)行消費(fèi)稅后，有些中藥的價(jià)格攀升多達(dá)50%，去年以來成本不斷上升。
傳統(tǒng)中藥除藥用外，也是華人的飲食如湯的重要組成部分?！吧特湼惺艿搅藟毫?，他們抱怨說生意減少了約40%-60%。”陳表示，由于全球經(jīng)濟(jì)和林吉特走弱，中藥價(jià)格毫無趨穩(wěn)跡象，消費(fèi)者和業(yè)者應(yīng)做好價(jià)格持續(xù)攀升的準(zhǔn)備。情況在中國新年后可能變得更嚴(yán)峻。他還說：“價(jià)格攀升的不僅是中草藥，還有用于推拿的藥酒和藥膏，價(jià)格上漲高達(dá)150%。”他表示，這對(duì)中醫(yī)發(fā)展造成了負(fù)面影響，患者因?yàn)槌杀究紤]可能不愿去中醫(yī)診所。
目前，像太子參等中藥價(jià)格比年初翻了2倍多，而常見的中藥材如當(dāng)歸和黨參，也上漲了約10%。南方大學(xué)學(xué)院中醫(yī)藥管委會(huì)主席林文賢(音)說，除了對(duì)傳統(tǒng)中藥需求高之外，另一個(gè)因素是近年來中國經(jīng)濟(jì)發(fā)展和生活方式及生活水平的提高。許多中國藥農(nóng)不再種植藥材，這對(duì)全球中醫(yī)藥行業(yè)造成了打擊。
